IM Cannabis (IMCC) Capital Expenditures (2020 - 2025)
Historic Capital Expenditures for IM Cannabis (IMCC) over the last 6 years, with Q3 2025 value amounting to -$2905.8.
- IM Cannabis' Capital Expenditures rose 9464.33% to -$2905.8 in Q3 2025 from the same period last year, while for Sep 2025 it was -$115184.3, marking a year-over-year decrease of 206.47%. This contributed to the annual value of -$113942.3 for FY2024, which is 7353.98% up from last year.
- Per IM Cannabis' latest filing, its Capital Expenditures stood at -$2905.8 for Q3 2025, which was up 9464.33% from -$21475.5 recorded in Q4 2024.
- In the past 5 years, IM Cannabis' Capital Expenditures ranged from a high of $6.2 million in Q4 2021 and a low of -$2.2 million during Q4 2022
- Over the past 5 years, IM Cannabis' median Capital Expenditures value was -$79979.1 (recorded in 2023), while the average stood at $121020.5.
- In the last 5 years, IM Cannabis' Capital Expenditures plummeted by 21135.72% in 2021 and then soared by 27601.98% in 2022.
- Over the past 5 years, IM Cannabis' Capital Expenditures (Quarter) stood at $6.2 million in 2021, then crashed by 135.26% to -$2.2 million in 2022, then soared by 99.05% to -$20567.0 in 2023, then decreased by 4.42% to -$21475.5 in 2024, then surged by 86.47% to -$2905.8 in 2025.
- Its Capital Expenditures stands at -$2905.8 for Q3 2025, versus -$21475.5 for Q4 2024 and -$54246.0 for Q3 2024.